. Author manuscript; available in PMC: 2012 Jun 1.

Published in final edited form as: Fam Cancer. 2011 Jun;10(2):213–223. doi: 10.1007/s10689-011-9425-2

Table 3.

Impact of sex of BRCA1/2 carrier on distress outcomes controlling for baseline and demographic factors

Variable	6-Month outcomes Z scores			12-Month outcomes Z scores
Variable	Cancer-specific distress	General distress	Genetic-testing distress	Cancer-specific distress	General distress	Genetic-testing distress
Associated baseline variable^a	8.82^***	4.00^***	5.35^***	8.54^***	3.08^**	4.86^***
Age	−1.17	0.12	−1.98^*	−2.08^*	−1.48	−2.03^*
# Sons ≤ 18 years	1.52	0.80	1.03	1.49	1.13	1.20
# Daughters ≤ 18 years	0.45	0.26	−0.05	−0.07	1.30	0.41
Family history total	1.90^b	1.92^b	0.52	0.29	−0.08	0.45
Married (vs. unmarried)	−1.23	−1.14	−0.65	−2.03^*	−2.16^*	−2.15^*
Jewish ethnicity (vs. not)	3.17	2.01^*	3.18^**	1.66^b	−0.27	1.16
Employed full-time (vs. not)	−1.35	−0.23	−1.02	−0.66	−0.52	−1.74^b
Study site (GU vs. NY/NJ)	3.00^**	1.65^b	1.59	2.19^*	1.17	1.52
Sex (Male vs. Female)	−0.30	0.85	−1.05	0.09	0.74	−1.89^b

We included the baseline variable associated with the specified outcome within the general estimating equation models. For genetic testing distress, we used cancer-specific distress at baseline, as we did not have a baseline measure of genetic testing distress

P < 0.10

P < 0.05;

^**

P < 0.01;

^***

P < 0.001